Ignacio Suárez-Lozano

Statistics

Publications

Citations

966

H-Index

Active since

2002

Affiliations

Hospital Universitario Infanta Leonor(Current)

Vall d'Hebron Hospital Universitari

Hospital Universitario La Paz

Hospital de Sant Pau

Universidad de Huelva

Ignacio Suárez-Lozano is an author at Hospital Universitario Infanta Leonor specializing in antiretroviral therapy, infectious diseases, and virology.

Publications per year

2002–2019

Publications

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

Amanda Mocroft, Jens Lundgren, Miriam Lewis Sabin et al. · PLoS Medicine · 2013 · 360 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +10

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

José A. Pérez‐Molina, Rafael Rubio, Antonio Rivero et al. · The Lancet Infectious Diseases · 2015 · 131 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde et al. · Clinical Infectious Diseases · 2017 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

José A. Pérez‐Molina, Rafael Rubio, Antonio Rivero et al. · Journal of Antimicrobial Chemotherapy · 2016 · 62 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Impact of Lamivudine on the Risk of Liver-Related Death in 2,041 Hbsag- and HIV-Positive Individuals: Results from An Inter-Cohort Analysis

Massimo Puoti, Alessandro Cozzi‐Lepri, Claudio Arici et al. · Antiviral Therapy · 2006 · 43 citations

Public Health, Infectious Diseases, Pharmacotherapy +17

1–5 of 17